STOCK TITAN

Xebra Announces Voting Results of its Annual General and Special Meeting

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) (FSE: 9YC0) announced successful voting results from their annual general and special meeting of Shareholders held on November 7, 2023. Shareholders voted in favor of all matters brought before them, including the appointment of auditors, setting the number of directors at seven, election of directors, and approval of a control person.
Positive
  • None.
Negative
  • None.

Vancouver, British Columbia--(Newsfile Corp. - November 16, 2023) - Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) (FSE: 9YC0) ("Xebra" or the "Company"), a cannabis company, is pleased to announce voting results from the Company's annual general and special meeting of Shareholders held on November 7, 2023 (the "Meeting"). A total of 18,935,030 common shares of the Company were represented at the Meeting, representing 34.73% of the total issued and outstanding shares of the Company as at the record date of September 28, 2023.

Shareholders voted in favour of all matters brought before them at the Meeting, which matters are discussed in detail in the Company's Management Information Circular dated September 28, 2023, that is available on SEDAR+ at www.sedarplus.com.

The following voting results are based on the total number of votes that were cast at the AGM:

Appointment of AuditorsForWithheldOutcome
Appoint Dale Matheson Carr-Hilton Labonte LLP, Auditors of the Company for the ensuing year and to authorize Directors to fix their remuneration17,877,907 (94.42%)1,057,123 (5.58%)Carried
 
   
Number of DirectorsForAgainstOutcome
Set the number of directors at seven (7)18,926,657 (99.96%)8,373 (0.04%)Carried
 
   
Election of DirectorsForWithheldOutcome
Elect the following nominees as directors of the Company


Jordi Chemonte18,885,237 (99.96%)7,089 (0.04%)Carried
Antonio Grimaldo18,885,237 (99.96%)7,089 (0.04%)Carried
Todd Dalotto18,682,058 (98.89%)210,268 (1.11%)Carried
Jay Garnett18,684,058 (98.90%)208,268 (1.10%)Carried
Erick Ponce18,884,498 (99.96%)7,828 (0.04%)Carried
Keith Dolo18,884,498 (99.96%)7,828 (0.04%)Carried
David Ross Macias Diaz18,888,637 (99.98%)3,689 (0.02%)Carried
 
   
Approval of Control Person ForAgainstOutcome
Approve David Ross Macias Diaz as a Control Person of the Company 18,887,830 (99.98%)4,496 (0.02%)Carried

 

ABOUT XEBRA

Xebra is an international cannabis cultivation and product company, with global brands and intellectual property. Our focus includes beverages, wellness and leisure. Xebra is an absolute first mover in the Mexican cannabis sector, with the first ever granted authorization to a corporation by the COFEPRIS. In Canada, Xebra retails its unique Vicious Citrus OG & NEO THC/CBN Lemonades.

Jay Garnett
CEO

For more information contact:
ir@xebrabrands.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/187579

FAQ

What was the outcome of Xebra Brands Ltd.'s annual general and special meeting of Shareholders?

Shareholders voted in favor of all matters brought before them, including the appointment of auditors, setting the number of directors at seven, election of directors, and approval of a control person.

Where can the Company's Management Information Circular be found?

The Company's Management Information Circular dated September 28, 2023, is available on SEDAR+ at www.sedarplus.com.

Who were elected as directors of the Company?

Jordi Chemonte, Antonio Grimaldo, Todd Dalotto, Jay Garnett, Erick Ponce, Keith Dolo, and David Ross Macias Diaz were elected as directors of the Company.

What percentage of the total issued and outstanding shares of the Company were represented at the Meeting?

A total of 18,935,030 common shares of the Company were represented at the Meeting, representing 34.73% of the total issued and outstanding shares of the Company as at the record date of September 28, 2023.

XEBRA BRANDS LTD

OTC:XBRAF

XBRAF Rankings

XBRAF Latest News

XBRAF Stock Data

3.53M
27.22%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Vancouver